Orthotopic cardiac transplantation in two patients with previous malignancy.
This report presents 2 patients with previous malignancy in whom congestive cardiomyopathy developed secondary to doxorubicin toxicity. Both patients underwent orthotopic cardiac transplantation 3 and 5 years ago and are now in functional class I with no evidence of malignant recurrence.
Hinkamp
T
T
Department of Thoracic and Cardiovascular Surgery, Loyola University Medical Center, Maywood, Illinois.
Sullivan
H
H
Bakhos
M
M
Grieco
J
J
Pifarré
R
R
D000328:Adult; D002311:Cardiomyopathy, Dilated / Q000139:chemically induced / Q000473:pathology / Q000601:surgery*; D004317:Doxorubicin / Q000009:adverse effects*; D005260:Female; D016027:Heart Transplantation / Q000379:methods; D006801:Humans; D009206:Myocardium / Q000648:ultrastructure; D012516:Osteosarcoma / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy
D004317:Doxorubicin